Northern Trust’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $71.8K | Sell |
65,836
-192,622
| -75% | -$210K | ﹤0.01% | 4174 |
|
2025
Q1 | $251K | Buy |
258,458
+14,068
| +6% | +$13.7K | ﹤0.01% | 3861 |
|
2024
Q4 | $362K | Buy |
244,390
+16,640
| +7% | +$24.6K | ﹤0.01% | 3768 |
|
2024
Q3 | $483K | Buy |
227,750
+169,152
| +289% | +$359K | ﹤0.01% | 3589 |
|
2024
Q2 | $143K | Buy |
58,598
+10,096
| +21% | +$24.6K | ﹤0.01% | 3959 |
|
2024
Q1 | $314K | Sell |
48,502
-1,146
| -2% | -$7.43K | ﹤0.01% | 3728 |
|
2023
Q4 | $192K | Buy |
49,648
+23,581
| +90% | +$91K | ﹤0.01% | 3912 |
|
2023
Q3 | $55.8K | Hold |
26,067
| – | – | ﹤0.01% | 4141 |
|
2023
Q2 | $79.5K | Buy |
26,067
+6,161
| +31% | +$18.8K | ﹤0.01% | 4098 |
|
2023
Q1 | $51.8K | Buy |
19,906
+1,467
| +8% | +$3.81K | ﹤0.01% | 4259 |
|
2022
Q4 | $37.8K | Sell |
18,439
-114
| -0.6% | -$234 | ﹤0.01% | 4351 |
|
2022
Q3 | $84K | Buy |
18,553
+4,735
| +34% | +$21.4K | ﹤0.01% | 4169 |
|
2022
Q2 | $57K | Sell |
13,818
-181,250
| -93% | -$748K | ﹤0.01% | 4371 |
|
2022
Q1 | $859K | Sell |
195,068
-4,997
| -2% | -$22K | ﹤0.01% | 3499 |
|
2021
Q4 | $2.38M | Buy |
200,065
+129,661
| +184% | +$1.54M | ﹤0.01% | 3141 |
|
2021
Q3 | $1.21M | Sell |
70,404
-5,370
| -7% | -$92.1K | ﹤0.01% | 3494 |
|
2021
Q2 | $1.32M | Buy |
+75,774
| New | +$1.32M | ﹤0.01% | 3468 |
|